Anti-tumor efficacy of 0114 blockade in combination with sunitinib or aflibercept in primary human renal cell carcinoma models

被引：0
|
作者：
Miles, Kiersten Marie [1 ]
Gillard, Bryan [1 ]
Kuhnert, Frank [2 ]
Thurston, Gavin [2 ]
Lalani, Alshad S. [2 ]
Pili, Roberto [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[2] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-2329
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2329
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Combination of novel intravesical xenogeneic urothelial cell immunotherapy and chemotherapy enhances anti-tumor efficacy in preclinical murine bladder tumor models
    Huang, Chi-Ping
    Wu, Chun-Chie
    Shyr, Chih-Rong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (05) : 1419 - 1433
  • [42] Potent anti-tumor activity of mTOR kinase inhibitor in combination with anti-angiogenic agents in preclinical models of renal cell cancer
    Wang, Shunyou
    Lan, Lucy
    Janes, Mathew
    Jessen, Katti
    Kessler, Linda
    Kucharski, Jeff
    Guo, Xin Xin
    Staunton, Jocelyn
    Elia, Marikka
    Banerjee, Urmi
    Stewart, Josh
    Dartania, Levan
    Li, Liansheng
    Chan, Katrina
    Martin, Mike
    Ren, Pingda
    Rommei, Christian
    Liu, Yi
    CANCER RESEARCH, 2012, 72
  • [43] Combination of novel intravesical xenogeneic urothelial cell immunotherapy and chemotherapy enhances anti-tumor efficacy in preclinical murine bladder tumor models
    Chi-Ping Huang
    Chun-Chie Wu
    Chih-Rong Shyr
    Cancer Immunology, Immunotherapy, 2021, 70 : 1419 - 1433
  • [44] Anti-tumor activity of cisplatin is enhanced by PD-1 blockade in preclinical models of head and neck squamous cell carcinoma
    Tran, Linda
    Allen, Clint T.
    Park, So-Jin
    Xiao, Roy
    Van Waes, Carter
    Schmitt, Nicole C.
    CANCER RESEARCH, 2017, 77
  • [45] Obatoclax, the pan-Bcl-2 inhibitor sensitizes hepatocellular carcinoma cells to promote the anti-tumor efficacy in combination with immune checkpoint blockade
    Li, Jingye
    Xu, Jinrong
    Li, Zhibing
    TRANSLATIONAL ONCOLOGY, 2021, 14 (08):
  • [46] CD24 blockade promotes anti-tumor immunity in oral squamous cell carcinoma
    Zou, Ke-Long
    Lan, Zhou
    Cui, Hao
    Zhao, Yu-Yue
    Wang, Wei-Ming
    Yu, Guang-Tao
    ORAL DISEASES, 2024, 30 (02) : 163 - 171
  • [47] Anti-tumor effects of bevacizumab in combination with paclitaxel on head and neck squamous cell carcinoma
    Fujita, Kyoko
    Sano, Daisuke
    Kimura, Machiko
    Yamashita, Yukiko
    Kawakami, Mariko
    Ishiguro, Yukari
    Nishimura, Goshi
    Matsuda, Hideki
    Tsukuda, Mamoru
    ONCOLOGY REPORTS, 2007, 18 (01) : 47 - 51
  • [48] Enhanced anti-tumor effects of TP300, a novel camptothecin analogue, in combination with other anti-tumor agents in human tumor xenograft models
    Endo, M.
    Ura, M.
    Tanimura, H.
    Taniguchi, K.
    Miyazaki, Y.
    Nagao, S.
    Okabe, H.
    Miwa, M.
    EJC SUPPLEMENTS, 2008, 6 (12): : 186 - 186
  • [49] A Listeria-based vaccine targeting ISG15 exerts anti-tumor efficacy in renal cell carcinoma
    Nguyen, Hong-My
    Oladejo, Mariam
    Paulishak, Wyatt
    Wood, Laurence M.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (09) : 2889 - 2903
  • [50] A Listeria-based vaccine targeting ISG15 exerts anti-tumor efficacy in renal cell carcinoma
    Hong-My Nguyen
    Mariam Oladejo
    Wyatt Paulishak
    Laurence M. Wood
    Cancer Immunology, Immunotherapy, 2023, 72 : 2889 - 2903
12345